Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01099358
Title	Study in Advanced Solid Tumors
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Eli Lilly and Company
Indications	Advanced Solid Tumor
Therapies	Cetuximab + Cisplatin Fluorouracil
Age Groups:	adult
Covered Countries	USA \| CAN

Filter rows:

Showing 1 to 7 of 7 entries

Facility	City	State	Zip	Country	Details
For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.	London		N6A 4L6	Canada	Details
For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.	Toronto		M5G 2M9	Canada	Details
Highlands Oncology Group	Fayetteville	Arkansas	72703	United States	Details
University of Kansas Medical Center	Fairway	Kansas	66205	United States	Details
University of North Carolina	Chapel Hill	North Carolina	27599	United States	Details
University of Texas Health Science Center - San Antonio	San Antonio	Texas	78229	United States	Details
VA Sierra Nevada Health Care System	Reno	Nevada	89502	United States	Details

Showing 1 to 7 of 7 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field